SCHEMBL19945665

SCHEMBL19945665

CCCSc1nc(N)c(NC)c(N(C=O)Cc2ccccc2)n1

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 5/20 0.38
▸ CTSB P07858 1/20 0.36
▸ ADORA3 P0DMS8 2/20 0.36
▸ ADORA1 P30542 2/20 0.36
▸ RAB9A P51151 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.33
▸ GLA P06280 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ PAK4 O96013 1/20 0.32
▸ GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19945779 0.90 MEN1 (0.36) ABCB1RAB9ASMN1; SMN2NPC1MAPT
SCHEMBL21318963 0.89 TSHR (0.31) —
SCHEMBL21318984 0.89 KMT2A (0.34) ABCB1ADORA3RAB9ANPC1CYP1A2
SCHEMBL21318940 0.88 ADORA3 (0.42) CTSBADORA3ADORA1KMT2A
SCHEMBL23772953 0.87 SMN1; SMN2 (0.37) CTSBADORA3ADORA1RAB9ASMN1; SMN2
SCHEMBL21318979 0.85 ADORA3 (0.34) CTSBADORA3ADORA1SMN1; SMN2CYP1A2
SCHEMBL21318986 0.85 ADORA3 (0.31) ADORA3ADORA1ALDH1A1KMT2AGAA
SCHEMBL21318976 0.85 ADORA3 (0.37) CTSBADORA3ADORA1SMN1; SMN2MAPT
SCHEMBL21319005 0.85 TLR7 (0.31) RAB9ASMN1; SMN2NPC1CYP1A2CYP2D6
SCHEMBL21318948 0.84 SRC (0.39) CTSBADORA3ADORA1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3865482-A1 7-SUBSTITUTED SULFONIMIDOYLPURINONE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF VIRUS INFECTION F. Hoffmann-La Roche AG (CH) 2021-08-18 — — EP disclosed
EP-3504210-B1 7-SUBSTITUTED SULFONIMIDOYLPURINONE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF VIRUS INFECTION HOFFMANN LA ROCHE (CH) 2021-02-24 — — EP disclosed
WO-2018041763-A1 7-SUBSTITUTED SULFONIMIDOYLPURINONE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF VIRUS INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2018-03-08 — — WO disclosed
Send feedback